What's Up and Coming in MCC

In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).

Related Videos
Related Content

POLL: What Type of Sunscreen Do You Recommend to Your Patients?

May 25th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SCALE 2023 Recap: Day 5

May 21st 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

Laying Down the Law of Cosmetic Procedures With David Goldberg, MD, JD

May 21st 2023

POLL: What Type of Sunscreen Do You Recommend to Your Patients?

May 25th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SCALE 2023 Recap: Day 5

May 21st 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

Laying Down the Law of Cosmetic Procedures With David Goldberg, MD, JD

May 21st 2023

POLL: What Type of Sunscreen Do You Recommend to Your Patients?

May 25th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SCALE 2023 Recap: Day 5

May 21st 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Topical Carboxytherapy and Human Platelet Extract Used as Peri-Procedural Adjuvant Following Non-Ablative Laser Resurfacing

May 21st 2023

Laying Down the Law of Cosmetic Procedures With David Goldberg, MD, JD

May 21st 2023
© 2023 MJH Life Sciences

All rights reserved.